{"id":15267,"date":"2014-06-15T17:18:43","date_gmt":"2014-06-15T09:18:43","guid":{"rendered":"https:\/\/canadianinquirer.net\/v1\/?p=15267"},"modified":"2014-06-15T17:18:43","modified_gmt":"2014-06-15T09:18:43","slug":"sanofi-medtronic-join-on-diabetes-drugs-devices","status":"publish","type":"post","link":"https:\/\/canadianinquirer.net\/v1\/2014\/06\/15\/sanofi-medtronic-join-on-diabetes-drugs-devices\/","title":{"rendered":"Sanofi, Medtronic join on diabetes drugs, devices"},"content":{"rendered":"<figure id=\"attachment_12672\" aria-describedby=\"caption-attachment-12672\" style=\"width: 1000px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2014\/05\/diabetes.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-12672\" src=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2014\/05\/diabetes.jpg\" alt=\"ShutterStock image\" width=\"1000\" height=\"667\" srcset=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2014\/05\/diabetes.jpg 1000w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2014\/05\/diabetes-300x200.jpg 300w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><\/a><figcaption id=\"caption-attachment-12672\" class=\"wp-caption-text\">ShutterStock image<\/figcaption><\/figure>\n<p>French drugmaker Sanofi and U.S. medical device manufacturer Medtronic Inc. have joined in a project to develop new combinations of drugs and devices for diabetes care.<\/p>\n<p>The two major companies announced Saturday the &#8220;global strategic alliance,&#8221; which they said was aimed at improving experience and results for people with diabetes around the world. The companies say the initial priorities will be developing drug-device combinations and providing care-management services to simplify insulin treatment.<\/p>\n<p>Paris-based Sanofi has expertise in developing insulin drugs while Minneapolis-based Medtronic makes insulin pumps and devices for monitoring glucose to control blood sugar.<\/p>\n<p>According to the World Health Organization, an estimated 347 million people worldwide have diabetes. In the U.S., about 30 million people have the disease.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>French drugmaker Sanofi and U.S. medical device manufacturer Medtronic Inc. have joined in a project to develop new combinations of &hellip;<\/p>\n","protected":false},"author":44,"featured_media":12672,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1482,37],"tags":[1890,5366,5365],"class_list":["post-15267","post","type-post","status-publish","format-standard","has-post-thumbnail","category-breaking","category-health","tag-diabetes","tag-medtronic","tag-sanofi","mauthors-the-associated-press"],"_links":{"self":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/15267","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/users\/44"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/comments?post=15267"}],"version-history":[{"count":0,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/15267\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media\/12672"}],"wp:attachment":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media?parent=15267"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/categories?post=15267"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/tags?post=15267"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}